Treatment of acute leukemia: usefulness of an immunodepressed unit Tratamiento de la leucemia aguda: utilidad de una unidad de inmunodeprimidos.
Author
dc.contributor.author
Gutiérrez,
Author
dc.contributor.author
Vargas Consuegra, Leandro Vargas
Author
dc.contributor.author
Bronfman,
Author
dc.contributor.author
Lorca,
Author
dc.contributor.author
Torrens,
Admission date
dc.date.accessioned
2019-01-29T14:49:21Z
Available date
dc.date.available
2019-01-29T14:49:21Z
Publication date
dc.date.issued
1990
Cita de ítem
dc.identifier.citation
Revista medica de Chile, Volumen 118, Issue 3, 2018, Pages 280-286
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160824
Abstract
dc.description.abstract
A special unit for immune-depressed patients was used in the treatment of acute leukemia in 33 patients. Results of therapy were compared to those in 30 historical controls treated in a general ward. Both groups were comparable regarding age, sex, type of leukemia and severity of bone marrow depression. The incidence of fever and the percentage of complete remission were higher in patients treated in the unit, including patients with acute lymphoblastic leukemia. The remission rate in the subgroup of patients with acute myeloid leukemia was not improved. Mortality rates were also not different. We recommend the use of this unit for treatment of patients with acute leukemia, given the lower infection rate and the higher probability of remission.